Zhengjia Liu
Changchun, 130031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Metal-polyphenol nanomedicines for malignant tumor therapy.
Journal: Frontiers in chemistry
Published: March 19, 2026
Identification of circRNA-Based Biomarkers and ceRNA Mechanism in Non-Small Cell Lung Cancer.
Journal: Cell biochemistry and biophysics
Published: April 02, 2025
Targeting Methylglyoxal Metabolism to Enhance Ferroptosis Sensitivity in Tumor Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 24, 2025
Plumbagin ameliorates LPS-induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1-Nrf2/HO-1 signalling pathways.
Journal: Journal of cellular and molecular medicine
Published: November 22, 2023
Perillaldehyde ameliorates lipopolysaccharide-induced acute lung injury via suppressing the cGAS/STING signaling pathway.
Journal: International immunopharmacology
Published: October 26, 2023
LINC01619 promotes non-small cell lung cancer development via regulating PAX6 by suppressing microRNA-129-5p.
Journal: American journal of translational research
Published: September 02, 2019
Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer.
Journal: Canadian respiratory journal
Published: May 05, 2019
LINC00210 plays oncogenic roles in non-small cell lung cancer by sponging microRNA-328-5p.
Journal: Experimental and therapeutic medicine
Published: November 28, 2018
Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway.
Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway.
Journal: Journal of cellular physiology
Published: November 15, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026